SOLARA ACTIVE PHARMA SCIENCE
|
|
BOM : 541540     NSE : SOLARA     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : Average [>25% and <50%] |
Mar 22,2023 |
Price(EOD): ₹ 365.80
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 1,316.88 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
SOLARA ACTIVE PHARMA SCIENCE | -5.4% | -2.5% | -48.3% |
SUN PHARMACEUTICAL INDUSTRIES | 0.5% | -1.3% | 4.6% |
DIVIS LABORATORIES | -0.4% | -3.9% | -37.8% |
CIPLA | -2.3% | -10.4% | -17.8% |
DR REDDYS LABORATORIES | 2.1% | 0.1% | 10.3% |
TORRENT PHARMACEUTICALS | -2.2% | 2.5% | 9.6% |
ABBOTT INDIA | 3.6% | 7.2% | 23.2% |
ZYDUS LIFESCIENCES | -0.3% | 3% | 30.4% |
ALKEM LABORATORIES | 2% | -1.8% | -11.2% |
FUNDAMENTAL ANALYSIS OF SOLARA ACTIVE PHARMA SCIENCE
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF SOLARA ACTIVE PHARMA SCIENCE
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
-54.43
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -24.19 Cr
[Latest Qtr - Dec2022 - Consolidated Results ] 0.86
P/B Calculated based on Book Value of Rs 1,523.87 Cr
[Latest Year - Mar2022 - Consolidated Results ] 0.92
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,424.01 Cr
[Latest Qtr - Dec2022 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
NA 111% -21% |
SHARE PRICE MOMENTUM OF SOLARA ACTIVE PHARMA SCIENCE
SOLARA ACTIVE PHARMA SCIENCE vs SENSEX
DEBT OF SOLARA ACTIVE PHARMA SCIENCE
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0.67 0.38 0.71 0.59 |
0.67 0.38 0.72 0.59 |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF SOLARA ACTIVE PHARMA SCIENCE
Pledged Promoter Shares |
33.73 % | |
---|---|---|
As on : Dec2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF SOLARA ACTIVE PHARMA SCIENCE
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
16.66% 63.22% 102.85% 104.31% |
293.41% 146.47% 100.39% 100.31% |
QtrlyTrend |
8 | |
Latest Qtr: Dec2022 | ||
Quarterly Result Analysis → |
SOLARA ACTIVE PHARMA SCIENCE related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE ALLCAP | 0.9% | -3.6% | -1.7% |
S&P BSE HEALTHCARE | 0.5% | -2.8% | -10.9% |
S&P BSE SMALL CAP | 0% | -3.1% | -1.9% |
S&P BSE MIDSMALLCAP | NA | -2.9% | -0.6% |
You may also like the below Video Courses
FAQ about SOLARA ACTIVE PHARMA SCIENCE
Is SOLARA ACTIVE PHARMA SCIENCE good for long term investment?
As on Mar 22,2023, the Fundamentals of SOLARA ACTIVE PHARMA SCIENCE look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of SOLARA ACTIVE PHARMA SCIENCE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is SOLARA ACTIVE PHARMA SCIENCE UnderValued or OverValued?
As on Mar 22,2023, SOLARA ACTIVE PHARMA SCIENCE is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of SOLARA ACTIVE PHARMA SCIENCE ?
As on Mar 22,2023, the Intrinsic Value of SOLARA ACTIVE PHARMA SCIENCE is Rs. 317.30 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. -55.54
Fair Value [Median EV / Sales Model] : Rs. 173.48
Fair Value [Median Price / Sales Model] : Rs. 461.13
Estimated Median Fair Value of SOLARA ACTIVE PHARMA SCIENCE : Rs. 317.30
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is SOLARA ACTIVE PHARMA SCIENCE trading at a Premium or Discount?
As on Mar 22,2023, SOLARA ACTIVE PHARMA SCIENCE is trading at a Premium of 15% based on the estimates of Median Intrinsic Value!